Read the latest medications for pediatric patients approved by the US Food and Drug Administration. The use of biologic therapies for managing chronic pediatric diseases such as atopic dermatitis and ...

RSV-associated lower respiratory tract infection hospitalization occurred in 0.86% of infants who received both RSVpreF exposure and nirsevimab. Most infants in the cohort received nirsevimab before ...

The AAP recommends swim lessons begin after a child’s first birthday as part of a layered drowning prevention strategy. Drowning deaths are increasing again in the United States, with disproportionate ...

Finding an acceptable alternative to breast milk has proved to be a complicated quest that continues today. Finding an acceptable alternative to breast milk has proved to be a complicated quest that ...

Discover mental health screening tools for the pediatric primary care provider. The National Association of Pediatric Nurse Practitioners called to prioritize integrating pediatric mental health into ...

The FDA acknowledged that the primary endpoint was met but that "data do not support the effectiveness of low-dose atropine in children with myopia," according to Sydnexis. FDA issued a complete ...

The FDA has approved once-weekly somapacitan-beco for children aged 2.5 years and older with 3 separate growth indications. The FDA has approved somapacitan-beco (Sogroya; Novo Nordisk) 5 mg, 10 mg, ...

The latest update to the HEEADSSS psychosocial interview for adolescents includes new questions on electronic media use in addition to its time-tested strategies for identifying the critical stressors ...

Caregivers and parents should feel empowered to protect their children with sun-safe practices that include sunscreen, sun-protective clothing, and sun-safe activities. According to the American ...

A collection of links for lesbian, gay, bisexual, transgender, and questioning youth, and their parents, friends, and doctors. Support and advice for LGBTQ youth requires an understanding of both ...

Despite the growing involvement of fathers in their children’s lives, there persists a lack of focus on fathers in pediatric care. Updated guidelines can help pediatricians to better engage fathers in ...

The FDA has assigned a target action date of February 28, 2026, for a potential expanded indication of pegvaliase-pqpz to include adolescents with PKU. FDA Priority Review accepted for pegvaliase-pqpz ...